Bird Flu Threat Still Looms, But HHS Just Canceled a Moderna Contract That Could Prepare for It - MedCity News
The avian influenza vaccine candidate mRNA-1018 showed promising interim results, yet the U.S. government has canceled the contract that would fund its late-stage trials.